Vertex Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERTEX PHARMS INC, and when can generic versions of VERTEX PHARMS INC drugs launch?
VERTEX PHARMS INC has five approved drugs.
There are thirty-nine US patents protecting VERTEX PHARMS INC drugs.
There are six hundred and seven patent family members on VERTEX PHARMS INC drugs in forty-four countries and fifty-seven supplementary protection certificates in nineteen countries.
Summary for Vertex Pharms Inc
International Patents: | 607 |
US Patents: | 39 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 5 |
Drugs and US Patents for Vertex Pharms Inc
International Patents for Vertex Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2013253111 | See Plans and Pricing |
Spain | 2790700 | See Plans and Pricing |
Spain | 2885181 | See Plans and Pricing |
Spain | 2554353 | See Plans and Pricing |
Morocco | 41051 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Vertex Pharms Inc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2404919 | CR 2016 00019 | Denmark | See Plans and Pricing | PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPANCATBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOSYRE, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ELLER ET ESTERPRODRUG DERAF; REG. NO/DATE: EU/1/15/1059 20151124 |
1773816 | 122015000050 | Germany | See Plans and Pricing | PRODUCT NAME: N-(5-HYDROXY-2,4-DI-TERT-BUTYL-PHENYL)-4-OXO-1H-CHINOLIN-3-CARBONSAEUREAMID ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/12/782/001-002 20120723 |
1773816 | CR 2015 00038 | Denmark | See Plans and Pricing | PRODUCT NAME: N-(5-HYDROXY-2,4-DITERT-BUTYL-PHENYL)-4-OXO-1H-QUINOLIN-3-CARBOXAMID ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/12/782/001-002 20120725 |
1773816 | C20150028 00162 | Estonia | See Plans and Pricing | PRODUCT NAME: IVAKAFTOOR;REG NO/DATE: EU/1/12/782/001-002 25.07.2012 |
1773816 | 35/2015 | Austria | See Plans and Pricing | PRODUCT NAME: N-(5-HYDROXY-2,4DITERT-BUTYL-PHENYL)-4-OXO-1H-QUINOLIN-3-CARBOXAMID ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/12/782/001, EU/1/12/782/002 (MITTEILUNG) 20120725 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.